|
Axsome Therapeutics Inc (NASDAQ: AXSM) |
|
Axsome Therapeutics Inc
AXSM's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Axsome Therapeutics Inc growth rates, revenue grew
by 69.81 % in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 229
Major Pharmaceutical Preparations industry recorded
growth of revenues by 4.44 %
Axsome Therapeutics Inc net loss decreased from $-99 millions, to $-59 millions in first quarter of 2025,
• More on AXSM's Growth
|
|
Axsome Therapeutics Inc realized a net loss in trailing twelve months.
Axsome Therapeutics Inc realized cash reduction of $ -1.75 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 12.15.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.44.
• More on AXSM's Valuation
|
|
|
|
|
Axsome Therapeutics Inc realized net loss in trailing twelve months.
Axsome Therapeutics Inc realized cash outflow of $ -1.75per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 12.15.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.44.
Axsome Therapeutics Inc Price to Book Ratio is at 102.6 higher than Industry Avg. of 34.77, and higher than S&P 500 Avg. of 0.01
• More on AXSM's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com